Boston Scientific Corporation (BSX)
| Market Cap | 56.21B |
| Revenue (ttm) | 9.91B |
| Net Income (ttm) | -115.00M |
| Shares Out | 1.42B |
| EPS (ttm) | 2.61 |
| PE Ratio | 15.23 |
| Forward PE | 24.75 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 25 |
| Last Price | $39.67 |
| Previous Close | $39.53 |
| Change ($) | 0.14 |
| Change (%) | 0.35% |
| Day's Open | 39.50 |
| Day's Range | 39.31 - 39.96 |
| Day's Volume | 11,651,678 |
| 52-Week Range | 24.10 - 42.37 |
We think that Henry Schein currently is a better pick compared to Boston Scientific. HSIC stock trades at about 0.9x trailing Revenues, compared to around 5.5x for Boston Scientific.
Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.
Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high.
Whether in transportation, manufacturing or healthcare, don't touch any of these 14 AI-related stocks with a 10-foot pole. Here's why.
MARLBOROUGH, Mass., Feb. 12, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences. On February 25, 2021, Dan Brennan, executive ...
Barring MedSurg, organic revenues at each of Boston Scientific (BSX) core segments and geographies are down in Q4 but the magnitude of this decline is lower than Q3.
Apart from a drop in Q4 earnings and revenues drop year over year, Boston Scientific (BSX) also registers strong sequential decline in overall financial performance.
Boston Scientific (BSX) delivered earnings and revenue surprises of -25.81% and -0.02%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the ...
Shares of Boston Scientific (NYSE:BSX) fell 2.0% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 50.00% year over year to $0.23, whi...
MARLBOROUGH, Mass., Feb. 3, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.708 billion during the fourth quarter of 2020. This represents a decline of...
New York, New York--(Newsfile Corp. - February 2, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...
LOS ANGELES--(BUSINESS WIRE)---- $BSX #BSX--DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Boston Scientific Corporation
New York, New York--(Newsfile Corp. - February 2, 2021) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) b...
New York, New York--(Newsfile Corp. - February 1, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Boston Scientific Corporation (...
LOS ANGELES, Feb. 1, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Boston Scientific Corporati...
New York, New York--(Newsfile Corp. - February 1, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...
NEW YORK, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Boston Scientific C...
NEW YORK, Feb. 1, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities cl...
NEW YORK, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) between April 2...
NEW YORK, Jan. 31, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: B...
New York, New York--(Newsfile Corp. - January 30, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: B...
New York, New York--(Newsfile Corp. - January 29, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...
LOS ANGELES--(BUSINESS WIRE)---- $BSX #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Boston Scientific Corporation (BSX)
New York, New York--(Newsfile Corp. - January 28, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Boston Scientific Corporation...
New York, New York--(Newsfile Corp. - January 28, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...
Per Boston Scientific's (BSX) October update, it has started to see strong region-wise recovery.
New York, New York--(Newsfile Corp. - January 27, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Boston Scientific Corporation (...
New York, New York--(Newsfile Corp. - January 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "C...
New York, New York--(Newsfile Corp. - January 26, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion...
The latest FDA approval of Boston Scientific's (BSX) fourth-generation Vercise Genus DBS System is aimed at improving patients' quality of life.
Amassing $1 million may be much more achievable than you think.
New York, New York--(Newsfile Corp. - January 25, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Boston Scientific Corporation (...
NEW YORK, Jan. 25, 2021 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has filed a class action suit in the United States District Court for the District of Massachusetts agai...
New York, New York--(Newsfile Corp. - January 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...
NEW YORK, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) between April 2...
New York, New York--(Newsfile Corp. - January 23, 2021) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) b...
LOS ANGELES, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 2, 2021 deadline to file a lead plaintiff motion in the class acti...
Boston Scientific's (BSX) acquisition of Preventice solutions enables the former to expand rhythm management diagnostics portfolio and abilities.
MARLBOROUGH, Mass., Jan. 22, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval of its fourth-generation Vercise Genus...
New York, New York--(Newsfile Corp. - January 21, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Boston Scientific Corporation (...
NEW YORK, Jan. 21, 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) between April 24, 2...
New York, New York--(Newsfile Corp. - January 21, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...
Boston Scientific Inc. said Thursday it has agreed to acquire privately held Preventice Solutions Inc. for an upfront payment of $925 million and up to $300 million in potential milestone paym...
MARLBOROUGH, Mass., Jan. 21, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a private...
The pandemic is only a temporary setback for this diversified global manufacturer of medical devices.
New York, New York--(Newsfile Corp. - January 20, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "...
LOS ANGELES, Jan. 20, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise a...
NEW YORK, NY / ACCESSWIRE / January 17, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you s...
New York, New York--(Newsfile Corp. - January 15, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Boston Scientific Corporation (...
About BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and r... [Read more...]
| Industry Medical Devices | IPO Date May 18, 1992 |
| CEO Michael Mahoney | Employees 36,000 |
| Stock Exchange NYSE | Ticker Symbol BSX |
Analyst Forecasts
According to 27 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price forecast is 43.36, which is an increase of 9.30% from the latest price.